Cargando…

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Pro

Detalles Bibliográficos
Autores principales:	Campbell, Steven C., Ornstein, Moshe C., Rathi, Nityam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Open to Debate: For
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9442329/ https://www.ncbi.nlm.nih.gov/pubmed/36071819 http://dx.doi.org/10.1016/j.euros.2022.05.019

Ejemplares similares

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Con
por: Kuusk, Teele, et al.
Publicado: (2022)

Partial Nephrectomy for Metastatic Renal Cell Carcinoma: Referee
por: Minervini, Andrea, et al.
Publicado: (2022)

Cytoreductive Nephrectomy: Still Necessary in 2021
por: Méjean, Arnaud, et al.
Publicado: (2022)

How to Deal with Renal Cell Carcinoma >7 cm: Radical Surgery
por: Grimm, Marc-Oliver, et al.
Publicado: (2021)

How To Deal with Renal Cell Carcinoma Tumors >7 cm: The Role of Nephron-sparing Surgery
por: Minervini, Andrea, et al.
Publicado: (2021)

Cytoreductive Nephrectomy in 2021: Obsolete
por: Meza, Luis, et al.
Publicado: (2021)

Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature
por: Dawsey, Scott J., et al.
Publicado: (2021)

Cytoreductive Nephrectomy in 2021: Obsolete but Necessary
por: Capitanio, Umberto, et al.
Publicado: (2021)

Every decade counts: a narrative review of functional recovery after partial nephrectomy
por: Campbell, Steven C., et al.
Publicado: (2022)

How to Deal with Renal Cell Carcinoma Tumours >7 cm: Referee
por: Abu-Ghanem, Yasmin, et al.
Publicado: (2021)

Conservative Treatment for Upper Urinary Tract Urothelial Carcinoma
por: Traxer, Olivier, et al.
Publicado: (2021)

Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy
por: Sayres, Lauren C, et al.
Publicado: (2012)

Radiotherapy is the Preferred Primary Tumor Treatment in Oligometastatic Prostate Cancer
por: van Moorselaar, R. Jeroen A., et al.
Publicado: (2022)

Nerve-sparing Techniques During Robot-assisted Radical Prostatectomy: Clips
por: Zhu, Alec, et al.
Publicado: (2022)

The tango of immunotherapy and targeted therapy in metastatic renal cell carcinoma
por: Rathi, Nityam, et al.
Publicado: (2019)

Robotic Partial Nephrectomy with En Bloc Removal of a Renal Vein Thrombus for Multiple cT3a Renal Cell Carcinoma Lesions
por: Grosso, Antonio Andrea, et al.
Publicado: (2022)

Prostate Cancer: Is There Still a Role for Systematic Biopsies? Yes
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

High-risk Locally Advanced Prostate Cancer: Multimodal Treatment Is the Key
por: Terlizzi, Mario, et al.
Publicado: (2022)

Which Is the Best Laser for Lithotripsy? Holmium Laser
por: Kim, Hyung Joon, et al.
Publicado: (2022)

Which Is the Best Laser for Lithotripsy? Thulium Fiber Laser
por: Traxer, Olivier, et al.
Publicado: (2022)

Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy: Extended, of Course
por: Gandaglia, Giorgio, et al.
Publicado: (2022)

Long Live Holmium!
por: Socarrás, Moisés Rodriguez, et al.
Publicado: (2022)

Thulium Fiber Laser: Bringing Lasers to a Whole New Level
por: Enikeev, Dmitry, et al.
Publicado: (2022)

Open science versus commercialization: a modern research conflict?
por: Caulfield, Timothy, et al.
Publicado: (2012)

An ethics safe harbor for international genomics research?
por: Dove, Edward S, et al.
Publicado: (2013)

Harvard Personal Genome Project: lessons from participatory public research
por: Ball, Madeleine P, et al.
Publicado: (2014)

Disentangling Public Participation In Science and Biomedicine
por: Kelty, Christopher, et al.
Publicado: (2014)

Constructing narratives of heroism and villainy: case study of Myriad's BRACAnalysis(® )compared to Genentech's Herceptin(®)
por: Baldwin, A Lane, et al.
Publicado: (2013)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer
por: Ceci, Francesco, et al.
Publicado: (2021)

TREXIT Is Now: Should We Abandon the Transrectal Route for Prostate Biopsy? Yes
por: Grummet, Jeremy P., et al.
Publicado: (2021)

Percutaneous Nephrolithotomy: Which Position? Supine Position!
por: Giusti, Guido, et al.
Publicado: (2021)

Percutaneous Nephrolithotomy for Stone Disease: Which Position? Prone Position!
por: Liatsikos, Evangelos, et al.
Publicado: (2021)

The Studer Neobladder: An Established and Reproducible Technique for Intracorporeal Urinary Diversion
por: Lavallée, Etienne, et al.
Publicado: (2021)

Retroperitoneal Lymph Node Dissection Should Be a Standard-of-Care Treatment Option For Stage II Seminoma
por: Alsyouf, Muhannad, et al.
Publicado: (2023)

How To Manage T3b Prostate Cancer in the Contemporary Era: Is Radiotherapy the Standard of Care?
por: Achard, Vérane, et al.
Publicado: (2023)

Partial nephrectomy for metastatic renal cell carcinoma: Where do we stand?
por: Shahait, Mohammed, et al.
Publicado: (2015)

The Effect of Cytoreductive Partial Nephrectomy in Elderly Patients with Metastatic Renal Cell Carcinoma
por: Chen, Jiabi, et al.
Publicado: (2020)

Addition of Salvage Immunotherapy to Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma
por: Dawsey, Scott J., et al.
Publicado: (2021)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Referee
por: Grobet-Jeandin, Elisabeth, et al.
Publicado: (2021)

Conservative Treatment of Upper Urinary Tract Urothelial Carcinoma: Con
por: Seles, Maximilian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3ha3dih8s3vv01c67jip9m7jve